1. Home
  2. ESPR vs ODC Comparison

ESPR vs ODC Comparison

Compare ESPR & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • ODC
  • Stock Information
  • Founded
  • ESPR 2008
  • ODC 1941
  • Country
  • ESPR United States
  • ODC United States
  • Employees
  • ESPR N/A
  • ODC N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • ODC Miscellaneous manufacturing industries
  • Sector
  • ESPR Health Care
  • ODC Consumer Discretionary
  • Exchange
  • ESPR Nasdaq
  • ODC Nasdaq
  • Market Cap
  • ESPR 305.0M
  • ODC 305.8M
  • IPO Year
  • ESPR 2013
  • ODC N/A
  • Fundamental
  • Price
  • ESPR $1.67
  • ODC $48.88
  • Analyst Decision
  • ESPR Buy
  • ODC
  • Analyst Count
  • ESPR 7
  • ODC 0
  • Target Price
  • ESPR $6.36
  • ODC N/A
  • AVG Volume (30 Days)
  • ESPR 4.2M
  • ODC 42.8K
  • Earning Date
  • ESPR 03-04-2025
  • ODC 03-11-2025
  • Dividend Yield
  • ESPR N/A
  • ODC 1.27%
  • EPS Growth
  • ESPR N/A
  • ODC 18.90
  • EPS
  • ESPR N/A
  • ODC 3.13
  • Revenue
  • ESPR $332,314,000.00
  • ODC $465,340,000.00
  • Revenue This Year
  • ESPR $5.51
  • ODC N/A
  • Revenue Next Year
  • ESPR $1.42
  • ODC N/A
  • P/E Ratio
  • ESPR N/A
  • ODC $15.27
  • Revenue Growth
  • ESPR 185.66
  • ODC 8.24
  • 52 Week Low
  • ESPR $1.47
  • ODC $29.48
  • 52 Week High
  • ESPR $3.94
  • ODC $49.72
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 48.04
  • ODC 62.83
  • Support Level
  • ESPR $1.47
  • ODC $46.99
  • Resistance Level
  • ESPR $1.61
  • ODC $49.72
  • Average True Range (ATR)
  • ESPR 0.13
  • ODC 1.82
  • MACD
  • ESPR 0.01
  • ODC 0.25
  • Stochastic Oscillator
  • ESPR 51.28
  • ODC 86.52

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups namely Retail and Wholesale Products Group and Business to Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

Share on Social Networks: